0.8 ML epcoritamab-bysp 60 MG/ML Injection
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
0.8 ML epcoritamab-bysp 60 MG/ML Injection
60 MG/ML · Injection · injection
A form of epcoritamab-bysp →
0.8 ML epcoritamab-bysp 60 MG/ML Injection — Other monoclonal antibodies and antibody drug conjugates. Strength, form, class, interactions & more.
Active ingredient
Classification
Other monoclonal antibodies and antibody drug conjugatesBispecific CD20-directed CD3 T Cell Engager
Drug interactions
Epcoritamab-bysp may affect the metabolism of certain CYP substrates, leading to increased exposure and potential toxicity.
- moderateCYP substrates — increased exposure leading to serious adverse reactions
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication